The Online Investor
Affymetrix Inc (AFFX)

Affymetrix provides life science tools and molecular diagnostic products for parallel analysis of biological systems at the gene, protein and cell level. Co. sells its products to genomic research centers, academic institutions, government and private laboratories, pharmaceutical, diagnostic and biotechnology companies. Co. has two segments: Affymetrix Core, which comprised of four business units: Expression, Genetic Analysis and Clinical Applications, Life Science Reagents,and Coporate; and eBioscience, which focused in the development, manufacturing, marketing and distribution of research tools for flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.
Company Name: 
Affymetrix Inc
Website: 
www.affymetrix.com
Sector: 
Biotechnology
Quotes delayed 20 minutes

Email EnvelopeFree AFFX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (1.83 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Affymetrix Inc (AFFX) Page | The Online Investor Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.